136 related articles for article (PubMed ID: 18679024)
1. Pentoxifylline inhibits transforming growth factor-beta signaling and renal fibrosis in experimental crescentic glomerulonephritis in rats.
Ng YY; Chen YM; Tsai TJ; Lan XR; Yang WC; Lan HY
Am J Nephrol; 2009; 29(1):43-53. PubMed ID: 18679024
[TBL] [Abstract][Full Text] [Related]
2. Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor.
Lin SL; Chen RH; Chen YM; Chiang WC; Lai CF; Wu KD; Tsai TJ
J Am Soc Nephrol; 2005 Sep; 16(9):2702-13. PubMed ID: 15987746
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
[TBL] [Abstract][Full Text] [Related]
4. Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling.
Fukasawa H; Yamamoto T; Suzuki H; Togawa A; Ohashi N; Fujigaki Y; Uchida C; Aoki M; Hosono M; Kitagawa M; Hishida A
Kidney Int; 2004 Jan; 65(1):63-74. PubMed ID: 14675037
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline Attenuates Proteinuria in Anti-Thy1 Glomerulonephritis via Downregulation of Nuclear Factor-κB and Smad2/3 Signaling.
Chen YM; Chiang WC; Yang Y; Lai CF; Wu KD; Lin SL
Mol Med; 2015 Apr; 21(1):276-84. PubMed ID: 25879629
[TBL] [Abstract][Full Text] [Related]
6. Latent TGF-beta1 protects against crescentic glomerulonephritis.
Huang XR; Chung AC; Zhou L; Wang XJ; Lan HY
J Am Soc Nephrol; 2008 Feb; 19(2):233-42. PubMed ID: 18216320
[TBL] [Abstract][Full Text] [Related]
7. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
[TBL] [Abstract][Full Text] [Related]
9. Myofibroblasts and the progression of crescentic glomerulonephritis.
Goumenos D; Tsomi K; Iatrou C; Oldroyd S; Sungur A; Papaioannides D; Moustakas G; Ziroyannis P; Mountokalakis T; El Nahas AM
Nephrol Dial Transplant; 1998 Jul; 13(7):1652-61. PubMed ID: 9681707
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
11. Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition.
Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2006 Jan; 290(1):F167-76. PubMed ID: 16048904
[TBL] [Abstract][Full Text] [Related]
12. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice.
Ka SM; Huang XR; Lan HY; Tsai PY; Yang SM; Shui HA; Chen A
J Am Soc Nephrol; 2007 Jun; 18(6):1777-88. PubMed ID: 17475816
[TBL] [Abstract][Full Text] [Related]
13. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease.
Goumenos DS; Tsamandas AC; Oldroyd S; Sotsiou F; Tsakas S; Petropoulou C; Bonikos D; El Nahas AM; Vlachojannis JG
Nephron; 2001 Mar; 87(3):240-8. PubMed ID: 11287759
[TBL] [Abstract][Full Text] [Related]
15. Low-dose paclitaxel ameliorates renal fibrosis by suppressing transforming growth factor-β1-induced plasminogen activator inhibitor-1 signaling.
Jung ES; Lee J; Heo NJ; Kim S; Kim DK; Joo KW; Han JS
Nephrology (Carlton); 2016 Jul; 21(7):574-82. PubMed ID: 26869361
[TBL] [Abstract][Full Text] [Related]
16. PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis.
Hohenstein B; Daniel C; Wittmann S; Hugo C
Nephrol Dial Transplant; 2008 Nov; 23(11):3427-36. PubMed ID: 18596129
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
Wang Y; Lin C; Ren Q; Liu Y; Yang X
Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
[TBL] [Abstract][Full Text] [Related]
18. Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation.
Li JH; Zhu HJ; Huang XR; Lai KN; Johnson RJ; Lan HY
J Am Soc Nephrol; 2002 Jun; 13(6):1464-72. PubMed ID: 12039975
[TBL] [Abstract][Full Text] [Related]
19. Effects of pentoxifylline on peritoneal fibroblasts and silica-induced peritoneal fibrosis.
Fang CC; Lai MN; Chien CT; Hung KY; Tsai CC; Tsai TJ; Hsieh BS
Perit Dial Int; 2003; 23(3):228-36. PubMed ID: 12938822
[TBL] [Abstract][Full Text] [Related]
20. Canonical transforming growth factor-β signaling regulates disintegrin metalloprotease expression in experimental renal fibrosis via miR-29.
Ramdas V; McBride M; Denby L; Baker AH
Am J Pathol; 2013 Dec; 183(6):1885-1896. PubMed ID: 24103556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
